Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Ensayo Clínico Dietético Adaptado Culturalmente en PR (PRECISION)

13 de noviembre de 2026 actualizado por: Josiemer Mattei, Harvard School of Public Health (HSPH)

Ensayo Clínico Dietético Adaptado Culturalmente en PR: Evaluación en Puerto Rico de una Intervención Sostenible Culturalmente Informada para una Nutrición Óptima (PRECISION)

This project will determine whether a diet culturally adapted to adults in Puerto Rico can effectively decrease cardiometabolic risk factors. This will help define a culturally-appropriate, feasible, and sustainable diet intervention aimed at reducing cardiovascular, type 2 diabetes, and obesity outcomes.

Descripción general del estudio

Descripción detallada

This intervention will culturally tailor a diet to the adult population in Puerto Rico based on staple foods as well as culturally appropriate strategies to reduce cardiometabolic risk factors. Based on preliminary results from studies on the island, investigators will conduct a 24-month, 2-arm intervention among 250-350 adults (125-175 per arm) ages 30-65 living in Puerto Rico with at least 1 of 5 cardiometabolic risk factors. The two arms are (1) intervention group with culturally-tailored portion-control Mediterranean Diet-like advice through monthly individual counseling for 12 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes, vegetable oils, and locally sourced assorted fruit and vegetables for 18 months; (2) control arm with portion-control standard non-tailored nutritional counseling in monthly individual sessions for 12 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18-24, we will monitor behavior maintenance (no food/voucher or counseling), with support from the nutritionist, and cues-to-action texts. Investigators will measure changes in cardiometabolic risk factors and metrics of eating behaviors and psychological factors. The two co-primary outcomes are changes in ASCVD score and cardiometabolic improvement score.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

250

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

      • San Juan, Puerto Rico, 00926
        • Reclutamiento
        • Puerto Rico Consortium for Clinical Investigation
        • Contacto:
        • Sub-Investigador:
          • Amarilys F Sylva, PhD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

30 años a 65 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  1. Age 30-65y old at the time of enrollment

  2. Non-institutionalized

  3. Living in PR at the time of recruitment and for at least the previous year and not planning to move from the island within the next 3 years

  4. Able to answer questions without assistance

  5. Having a cellphone with the capacity to receive text messages and be willing to receive daily text messages from the study on the designated cellphone number

  6. Having at least one of the following:

    1. elevated BMI
    2. elevated waist circumference
    3. self-reported physician-diagnosed hypertension or use of hypertension medication or measured high blood pressure at the baseline visit
    4. self-reported physician-diagnosed pre-diabetes or measured pre-diabetes at the baseline visit
    5. self-reported physician-diagnosed dyslipidemia or use of lipid-lowering agents or laboratory values confirming dyslipidemia

Exclusion Criteria:

  1. Under 30 or over 65 years of age (on the day of the interview).
  2. Currently not living in Puerto Rico or not lived on the island for at least 1 year or planning to move within 3 years
  3. Institutionalized
  4. Not able to answer questions without assistance
  5. Not having at least 1 of the five listed metabolic criteria
  6. Self-reported physician-diagnosed type 1 or type 2 diabetes or use of diabetes medication (including insulin) or diabetes-diagnosis values confirmed by laboratory
  7. Self-reported pregnancy
  8. Gastrointestinal or chronic condition that would impact eating behaviors or nutritional status
  9. Intolerance or allergies to legumes (i.e.: beans and nuts), vegetable oils (i.e.: corn, olive, canola), or fresh produce
  10. Living with another person participating in the study
  11. Participating in another research study that conflicts with PRECISION

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Triple

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Intervention

Intervention group will receive culturally-tailored portion-control Mediterranean-like advice through monthly individual counseling for 6 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes (i.e., beans and peanuts), vegetable oils (i.e., olive oil + a blend of canola and soybean), and locally sourced assorted fruit and vegetables for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no food or counseling) with support from the nutritionist available.

Puerto Rico-tailored education includes strategies for healthy eating, preferences for traditional healthy foods, recommendations for limiting unhealthy traditional foods, portion sizes, etc.

Comparador activo: Control

Control group will receive portion-control standard non-tailored nutritional counseling in monthly individual sessions for 6 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no voucher or counseling), with support from the nutritionist available.

Standard healthy eating education includes strategies, foods, portions, and cooking and eating tips included in the My Plate For A Healthy Puerto Rico dietary recommendations.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
10-year risk score for a first atherosclerotic CVD event (ASCVD score)
Periodo de tiempo: 6; 12; 18; 24 months

Estimate the change in first atherosclerotic CVD event (ASCVD) score; the score is calculated using the Pooled Cohort Equation which accounts for biological sex, age, race, total cholesterol, HDL-C, systolic blood pressure, treatment for high blood pressure, current diabetes diagnosis, and smoking status. Scores are expressed as percentage (0-100) with higher scores indicative of higher 10-year risk for ASCVD event. It is categorized as low-risk <5%; borderline risk 5% to 7.4%; intermediate risk 7.5% to 19.9%; and high risk ≥20%.

6; 12; 18; 24 months
Cardiometabolic Improvement Score (CIS)
Periodo de tiempo: 6; 12; 18; 24 months

Estimate the change in the score; calculated as the added number of risk factors changed over a predefined value; range of 0 to 10; from less to more improvement.

6; 12; 18; 24 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Changes in diet quality score
Periodo de tiempo: 6; 12; 18; 24 months

Determine the change in score of short diet quality screener (range 18-54; from lowest to highest quality)

6; 12; 18; 24 months
Changes in diet satisfaction: diet satisfaction scale
Periodo de tiempo: 6; 12; 18; 24 months

Determine the change in the score of the Diet Satisfaction Questionnaire (DSat-45) (range 45-225; from lowest to highest satisfaction) and its summed seven subscales (ranges 5-40)

6; 12; 18; 24 months
Changes in intake of pre-specified food groups (fruit; vegetables; legumes; oils; meat; fat)
Periodo de tiempo: 6; 12; 18; 24 months

Determine the change in servings/week of food groups

6; 12; 18; 24 months
Change in levels of waist circumference
Periodo de tiempo: 6; 12; 18; 24 months

Estimate the change in the value of waist circumference (cm)

6; 12; 18; 24 months
Change in levels of BMI
Periodo de tiempo: 6; 12; 18; 24 months

Estimate the change in the value of body mass index (kg/m2)

6; 12; 18; 24 months
Change in levels of blood pressure risk factors
Periodo de tiempo: 6; 12; 18; 24 months

Estimate the change in the value of systolic and diastolic blood pressure (mmHg)

6; 12; 18; 24 months
Change in levels of metabolic risk factors
Periodo de tiempo: 6; 12; 18; 24 months

Estimate the change in the value of glucose, triglycerides, total cholesterol, LDL, HDL (mg/dL)

6; 12; 18; 24 months
Change in food security status
Periodo de tiempo: 6; 12; 18; 24 months

Estimate the change in food security status assessed by the USDA Food Security Module

6; 12; 18; 24 months
Change in self-efficacy score
Periodo de tiempo: 6; 12; 18; 24 months

Estimate the change in self-efficacy score assessed by the Nutritional Self-Efficacy Scale

6; 12; 18; 24 months

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in social connectedness score
Periodo de tiempo: 6; 12; 18; 24 months

Estimate the change in social connectedness score from the Social Connectedness Scale/Social Assurance Scale

6; 12; 18; 24 months
Change in social support score
Periodo de tiempo: 6; 12; 18; 24 months

Estimate the change in social support score from the 12-item Social Support Scale

6; 12; 18; 24 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Josiemer Mattei, PhD, MPH, Harvard Chan School of Public Health
  • Director de estudio: Amarilys F Sylva, PhD, Puerto Rico Consortium for Clinical Investigations

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

2 de mayo de 2024

Finalización primaria (Estimado)

2 de mayo de 2029

Finalización del estudio (Estimado)

2 de mayo de 2029

Fechas de registro del estudio

Enviado por primera vez

14 de julio de 2023

Primero enviado que cumplió con los criterios de control de calidad

21 de julio de 2023

Publicado por primera vez (Actual)

27 de julio de 2023

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

13 de noviembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

IPD will be managed and distributed observing NIH and IRB policies on the dissemination and sharing of research results. Study information and requests for data will be available immediately upon the data being de-identified and properly revised for quality control by contacting study investigators.

Marco de tiempo para compartir IPD

10 years

Criterios de acceso compartido de IPD

The requested data will be shared with investigators via a secured, password-protected software website, upon request.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir